Abstract
Abstract Poly (aspartic acid-co-leucine) (PL) synthesized with aspartic acid and leucine was conjugated to 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA) by ethylenediamine. Then the compound obtained was chelated with gadolinium (III) to form PL-A 2 -DOTA-Gd. The structure of PL-A 2 -DOTA-Gd was characterized by nuclear magnetic resonance and gel chromatography and its performance was evaluated by cytotoxicity test, heamolysis test, in vitro relaxivity determination and animal in vivo magnetic resonance characterization. PL-A 2 -DOTA-Gd exhibited much lower cytotoxicity than Gd-DOTA. The T1-relaxivity of PL-A 2 -DOTA-Gd (15.3 mM −1 s −1 ) was 2.6 times than that of Gd-DOTA (5.8 mM −1 s −1 ) in D 2 O. The results of magnetic resonance imaging (MRI) experiments showed a significant enhancement in the rat liver imaging after the intravenous administration of PL-A 2 -DOTA-Gd. In addition, the imaging time persisted by using PL-A 2 -DOTA-Gd than that of Gd-DOTA and the imaging effect of liver tissue was enhanced by an average of 65.1% ± 5.2% and 21.3% ± 4.9% for PL-A 2 -DOTA-Gd and Gd-DOTA, respectively.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
